Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases Academic Article uri icon

Overview

MeSH Major

  • Hemangiopericytoma
  • Radiosurgery
  • Sarcoma
  • Spinal Neoplasms

abstract

  • We report the first analysis on the utility of DCE-MRI for metastatic sarcoma spine metastases treated with SBRT. We demonstrate that early assessment at 2 months post-SBRT using size and subjective neuroradiology impressions is insufficient to judge ultimate disease progression, and that a combination of perfusion parameters provides excellent correlation to local control.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5665020

Digital Object Identifier (DOI)

  • 10.1016/j.spinee.2015.08.041

PubMed ID

  • 26325017

Additional Document Info

start page

  • 291

end page

  • 8

volume

  • 16

number

  • 3